Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with 40mg of Rosuvastatin for 8
weeks will reduce the number of episodes of myocardial ischaemia suffered in subjects with
coronary artery disease.